YouLabs
Category: AI in Healthcare
Singapore and Hyderabad-based healthcare platform building preventive health and longevity infrastructure for South Asian populations, combining AI-driven Longevity Score, physician-managed programmes, and precision supplements. YouLabs was founded in 2025. The company is led by Ajay Bulusu. Based in Singapore & Hyderabad, India. Team size: 11-50. Total funding raised: $2.6M. Latest round: Seed. Key investors include Crane Venture Partners, Dr. Reddy's, Matrix Pharma, Jayanti Reddy.
- Founded
- 2025
- Headquarters
- Singapore & Hyderabad, India
- Team size
- 11-50
- Total funding
- $2.6M
Value proposition
Building the clinical infrastructure, data architecture, and physician programmes that define Indian precision medicine — shifting healthcare from disease treatment to continuous health monitoring and prevention for South Asian populations.
Products and solutions
150 (physician-managed preventive health & longevity programme, WhatsApp-first executive health concierge for India's ultra-high-net-worth families), Longevity Score (proprietary AI combining genomic, biological and longitudinal health data), Longevity-focused supplements (initially for 150 programme participants), Health data platform focused on South Asian populations
Unique value
WhatsApp-first executive health concierge combining AI-driven Longevity Score, physician-managed protocols, and precision supplements specifically designed for South Asian populations — a population dramatically underrepresented in modern health infrastructure.
Target customer
Ultra-high-net-worth individuals and families in India; South Asian populations seeking preventive health and longevity management
Industries served
Preventive Health, Longevity Medicine, Precision Medicine, Health Data Infrastructure
Technology advantage
AI-driven Longevity Score combining genomic, biological, and longitudinal health data; WhatsApp-first delivery model for high-engagement preventive care; Proprietary health data platform focused on South Asian populations; Multi-modal biomarker integration (genomics, epigenetics, gut microbiome, HRV/RHR/sleep from wearables)
How they differentiate
Focus exclusively on South Asian populations (genomic, biological, and longitudinal data gap); WhatsApp-first concierge model for UHNI families; Physician-managed programme (150) combining AI, clinical practice, and supplements; Proprietary Longevity Score combining multi-modal data (genomics, epigenetics, gut microbiome, wearables)
Main competitors
Longevity AI, MyHealthspan, Human Longevity Inc.
Key partnerships
Crane Venture Partners (lead investor, first APAC fund investment), Dr. Reddy's (investor), Matrix Pharma (investor)
Major milestones
June 2026: Raised $2.6M seed round led by Crane Venture Partners (first investment from Crane's APAC fund), 2026: Launching first product "150" — physician-managed preventive health & longevity programme, Building proprietary Longevity Score combining genomic, biological and longitudinal health data
Market positioning
Early-stage preventive health platform specifically targeting the South Asian longevity market gap, with a premium UHNI-focused go-to-market strategy through the 150 programme
Geographic focus
India (primary), Singapore (HQ), South Asian populations globally
About Ajay Bulusu
Ex-Google (2011); Founding member of Geo team at Grab; Co-founder of NextBillion.ai (NB.ai, acquired); 2x Fortune 40 Under 40
Official website: https://youlabs.co